Barriers and facilitators to evidence based care of type 2 diabetes patients: Experiences of general practitioners participating to a quality improvement program

Implementation Science

Volumn 4, Issue 1, 2009, Pages

  Goderis, Geert ^a   Borgermans, Liesbeth ^a   Mathieu, Chantal ^b   Van Den Broeke, Carine ^a   Hannes, Karin ^a   Heyrman, Jan ^a   Grol, Richard ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68749114127     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-4-41     Document Type: Article

References (49)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med 1993 329 977 986 10.1056/NEJM199309303291401 8366922 (Pubitemid 23307905)
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998 352 837 853 10.1016/S0140-6736(98)07019-6 9742976 (Pubitemid 28416718)
3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998 352 854 865 10.1016/S0140-6736(98)07037-8 9742977 (Pubitemid 28416719)
4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2ádiabetes: UKPDS 38. UK Prospective Diabetes Study Group, BMJ 1998 317 703 713 9732337
5. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group, BMJ 1998 317 713 720 9732338
6. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. P Gaede P Vedel N Larsen GV Jensen HH Parving O Pedersen, N Engl J Med 2003 348 383 393 10.1056/NEJMoa021778 12556541 (Pubitemid 36159355)
7. Lipid-lowering therapy in people with type 2 diabetes. S Colagiuri J Best, Curr Opin Lipidol 2002 13 617 623 10.1097/00041433-200212000-00004 12441885 (Pubitemid 36009200)
8. Effect of a multifactorial intervention on mortality in type 2 diabetes. P Gaede H Lund-Andersen HH Parving O Pedersen, N Engl J Med 2008 358 580 591 10.1056/NEJMoa0706245 18256393 (Pubitemid 351214285)
9. 10-year follow-up of intensive glucose control in type 2 diabetes. RR Holman SK Paul MA Bethel DR Matthews HA Neil, N Engl J Med 2008 359 1577 1589 10.1056/NEJMoa0806470 18784090
10. Standards of medical care in diabetes 2007. American Diabetes Association, Diabetes Care 2007 30 Suppl 1 S4 S41 10.2337/dc07-S004 17192377 (Pubitemid 46048398)
11. The knowledge-action gap in diabetes. BA Bowman F Vinicor, Nutr Clin Care 2003 6 49 50 14692292
12. The use and perceived value of diabetes clinical management guidelines in general practice. N Faruqi J Frith S Colagiuri M Harris, Aust Fam Physician 2000 29 173 176 10743276
13. K McDonald V Sundaram DM Bravavata R Lewis N Lin S Kraft M McKinnon H Paguntalan DK Owens, Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies Volume 7-Care Coordination (Technical Review 9 (Prepared by the Stanford University-UCSF Evidence-based Practice Center under contract 290-02-0017) 2007
14. KG Shojania SR Ranji LK Shaw LN Charo JC Lai RJ Rushakoff KM McDonald DK Owens, Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies Volume 2-Diabetes Mellitus Care, Technical review 9 (Contract No. 290-02-0017 to the Stanford University-UCSF Evidence-based Practice Center) 2004
15. Effectiveness and efficiency of guideline dissemination and implementation strategies. JM Grimshaw RE Thomas G MacLennan C Fraser CR Ramsay L Vale P Whitty MP Eccles L Matowe L Shirran, Health Technol Assess 2004 8 14960256
16. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. AC Larme JA Pugh, Diabetes Care 1998 21 1391 1396 10.2337/diacare.21.9.1391 9727882
17. Physician-related barriers to hypertension management. L Wang, Med Princ Pract 2004 13 282 285 10.1159/000079528 15316262 (Pubitemid 39179143)
18. Perceived barriers and effective strategies to diabetes self-management. J Nagelkerk K Reick L Meengs, J Adv Nurs 2006 54 151 158 10.1111/j.1365-2648. 2006.03799.x 16553701
19. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care. J Kedward L Dakin, Br J Gen Pract 2003 53 684 689 15103875
20. Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers. S Nakar G Yitzhaki R Rosenberg S Vinker, J Diabetes Complications 2007 21 220 226 10.1016/j.jdiacomp.2006.02.004 17616351 (Pubitemid 47002315)
21. Primary care management of diabetes in a low/middle income country: a multi-method, qualitative study of barriers and facilitators to care. H Alberti N Boudriga M Nabli, BMC Fam Pract 2007 8 63 17996084 10.1186/1471-2296-8-63
22. Barriers to providing diabetes care in community health centers. MH Chin S Cook L Jin ML Drum JF Harrison J Koppert F Thiel AG Harrand CT Schaefer HT Takashima, Diabetes Care 2001 24 268 274 10.2337/diacare.24.2.268 11213877 (Pubitemid 32119123)
23. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. M Haque SH Emerson CR Dennison M Navsa NS Levitt, S Afr Med J 2005 95 798 802 16341336 (Pubitemid 41601169)
24. Providers' assessment of barriers to effective management of hypertension and hyperlipidemia in community health centers. S Cook ML Drum AC Kirchhoff L Jin J Levie JF Harrison SA Lippold CT Schaefer MH Chin, J Health Care Poor Underserved 2006 17 70 85 10.1353/hpu.2006.0021 16520513
25. Planning and studying improvement in patient care: the use of theoretical perspectives. RP Grol MC Bosch ME Hulscher MP Eccles M Wensing, Milbank Q 2007 85 93 138 10.1111/j.1468-0009.2007.00478.x 17319808
26. What drives change? Barriers to and incentives for achieving evidence-based practice. R Grol M Wensing, Med J Aust 2004 180 S57 S60 15012583
27. R Grol M Wensing M Eccles, Improving Patient Care. The implementation of Change in Clinical Practice 2005
28. D Fisher, Communication in organizations South-Western Educational Publishing 1993
29. GPs' perspectives of type 2 diabetes patients' adherence to treatment: A qualitative analysis of barriers and solutions. J Wens E Vermeire PV Royen B Sabbe J Denekens, BMC Fam Pract 2005 6 20 15890071 10.1186/1471-2296-6-20 (Pubitemid 40945034)
30. The theory of planned behaviour. I Ajzen, Organizational Behavior and Human Decision Processes 1991 50 179 211 10.1016/0749-5978(91)90020-T
31. Organizational interventions employing principles of complexity science have improved outcomes for patients with Type II diabetes. LK Leykum J Pugh V Lawrence M Parchman PH Noel J Cornell RR McDaniel Jr, Implement Sci 2007 2 28 17725834 10.1186/1748-5908-2-28
32. A qualitative investigation of the views and health beliefs of patients with Type 2 diabetes following the introduction of a diabetes shared care service. SM Smith M O'Leary G Bury W Shannon A Tynan A Staines C Thompson, Diabet Med 2003 20 853 857 10.1046/j.1464-5491.2003.01071.x 14510868 (Pubitemid 41701508)
33. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. MJ Davies S Heller TC Skinner MJ Campbell ME Carey S Cradock HM Dallosso H Daly Y Doherty S Eaton, BMJ 2008 336 491 495 18276664 10.1136/bmj.39474.922025.BE (Pubitemid 351347415)
34. Systematic review: an evaluation of major commercial weight loss programs in the United States. AG Tsai TA Wadden, Ann Intern Med 2005 142 56 66 15630109
35. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. SL Norris MM Engelgau KM Narayan, Diabetes Care 2001 24 561 587 10.2337/diacare.24.3.561 11289485
36. Different models to mobilize peer support to improve diabetes self-management and clinical outcomes: evidence, logistics, evaluation considerations and needs for future research. M Heisler, Fam Pract 2009 19293400
37. Peer support in type 2 diabetes: a randomised controlled trial in primary care with parallel economic and qualitative analyses: pilot study and protocol. GM Paul SM Smith DL Whitford E O'Shea F O'Kelly T O'Dowd, BMC Fam Pract 2007 8 45 17672892 10.1186/1471-2296-8-45 (Pubitemid 47301205)
38. A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic. A Beck J Scott P Williams B Robertson D Jackson G Gade P Cowan, J Am Geriatr Soc 1997 45 543 549 9158573
39. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. EH Wagner LC Grothaus N Sandhu MS Galvin M McGregor K Artz EA Coleman, Diabetes Care 2001 24 695 700 10.2337/diacare.24.4.695 11315833
40. Coping with complexity: educating for capability. SW Fraser T Greenhalgh, BMJ 2001 323 799 803 11588088 10.1136/bmj.323.7316.799
41. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. S Kripalani F LeFevre CO Phillips MV Williams P Basaviah DW Baker, JAMA 2007 297 831 841 10.1001/jama.297.8.831 17327525 (Pubitemid 46333948)
42. Medical errors related to discontinuity of care from an inpatient to an outpatient setting. C Moore J Wisnivesky S Williams T McGinn, J Gen Intern Med 2003 18 646 651 12911647 10.1046/j.1525-1497.2003.20722.x (Pubitemid 37047038)
43. A review of the job satisfaction and current practice of consultant diabetologists in England barriers and successes. K Macleod M Carter A Asprey N Britten J Dean R Hillson A Mackie N Morrish, Diabet Med 2007 24 946 954 10.1111/j.1464-5491.2007.02242.x 17725707 (Pubitemid 47301647)
44. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. DE Bonds EM Kurashige R Bergenstal D Brillon M Domanski JV Felicetta VA Fonseca K Hall I Hramiak ME Miller, Am J Cardiol 2007 99 80i 89i 10.1016/j.amjcard.2007.03.026 17599428 (Pubitemid 46961887)
45. Effects of intensive glucose lowering in type 2 diabetes. HC Gerstein ME Miller RP Byington DC Goff Jr JT Bigger JB Buse WC Cushman S Genuth F Ismail-Beigi RH Grimm Jr, N Engl J Med 2008 358 2545 2559 10.1056/NEJMoa0802743 18539917 (Pubitemid 351831356)
46. Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases: Implications for Pay for Performance. CM Boyd J Darer C Boult LP Fried L Boult AW Wu, JAMA 2005 294 716 724 10.1001/jama.294.6. 716 16091574 (Pubitemid 41159291)
47. Diagnosis, treatment and follow up of diabetes mellitus in elderly. C Hader W Beischer A Braun M Dreyer A Friedl I Fusgen U Gastes D Grunklee H Hauner J Kobberling, European Journal of Geriatrics 2006 8 1 57
48. Guidelines for improving the care of the older person with diabetes mellitus. AF Brown CM Mangione D Saliba CA Sarkisian, J Am Geriatr Soc. 2003 51 5 Suppl Guidelines S265 S280 10.1034/j.1600-0579.2003.00211.x 12694461 (Pubitemid 36541431)
49. Clinical Guidelines for type 2 diabetes Mellitus, European Daibetes Working Party for Older People. European Union Geriatric Medicine Society, 2004